Age ≥70 years |
1129 (42.9%) |
22 (55.0%) |
1.62 |
0.86–3.04 |
0.14 |
Sex (male) |
1948 (74.0%) |
30 (75.0%) |
1.053 |
0.51–2.16 |
0.52 |
BMI ≥30 |
903 (34.3%) |
25 (62.5%) |
3.19 |
1.67–6.08 |
0.001 |
Smoking |
478 (18.1%) |
6 (15.0%) |
0.79 |
0.33–1.90 |
0.83 |
Alcohol consumption (male >21 unit/week, female >14 unit/week) |
598 (22.7%) |
10 (25%) |
1.13 |
0.55–2.33 |
0.70 |
CCS 2 and 3 |
1006 (38.2%) |
23 (57.5%) |
2.18 |
1.16–4.11 |
0.021 |
New York Heart Association classification (NYHA) 3 and 4 |
1257 (47.7%) |
23 (57.5%) |
1.48 |
0.78–2.78 |
0.26 |
Diabetes |
578 (21.9%) |
12 (30.0%) |
1.52 |
0.77–3.01 |
0.24 |
Hypertension |
1824 (69.3%) |
35 (87.5%) |
3.10 |
1.21–7.94 |
0.014 |
Endocarditis |
59 (2.2%) |
0 |
|
|
0.40 |
Triple CAD |
1306 (49.6%) |
26 (65%) |
1.98 |
1.01–3.62 |
0.049 |
Left ventricle ejection fraction (<50%) |
521 (19.8%) |
9 (22.5%) |
1.176 |
0.55–2.48 |
0.68 |
Preoperative MI |
855 (32.4%) |
22 (55.0%) |
2.54 |
1.35–4.76 |
0.004 |
Antibiotic therapy up to operation |
247 (9.38%) |
6 (15.0%) |
1.70 |
0.70–4.09 |
0.26 |
PVD |
370 (14.0%) |
9 (22.5%) |
1.77 |
0.83–3.75 |
0.16 |
Renal failure |
47 (1.7%) |
1 (2.5%) |
1.41 |
0.19–10.48 |
0.51 |
Cerebrovascular accident (CVA) |
256 (9.7%) |
3 (7.5%) |
0.75 |
0.23–2.4 |
0.44 |
COPD |
129 (4.9%) |
2 (5.0%) |
1.02 |
0.24–4.28 |
0.59 |
Asthma |
126 (4.7%) |
3 (7.5%) |
1.61 |
0.49–5.3 |
0.44 |
IV nitrate infusion up to operation |
101 (3.8%) |
5 (12.5%) |
3.58 |
1.37–9.33 |
0.019 |
Mechanical ventilation |
18 (0.6%) |
0 |
|
|
0.76 |
Inotrope infusion >24 h |
15 (0.5%) |
0 |
|
|
0.79 |
IABP |
122 (4.6%) |
0 |
|
|
0.25 |
Perioperative |
Logistic EuroSCORE >5 |
851 (32.3%) |
17 (42.5%) |
1.54 |
0.82–2.91 |
0.17 |
Emergency operation |
110 (4.1%) |
0 |
|
|
0.41 |
LIMA harvest |
1508 (57.2%) |
21 (52.5%) |
0.63 |
0.44–1.54 |
0.32 |
BIMA harvest |
156 (5.9%) |
11 (27.5%) |
6.02 |
2.9–12.2 |
0.001 |
Valve operation |
1008 (38.3%) |
12 (30.0%) |
0.69 |
0.35–1.36 |
0.18 |
Redo-sternotomy |
64 (2.4%) |
2 (5.0%) |
2.11 |
0.49–8.94 |
0.26 |
Operation time (incision to closure) >270 min |
247 (9.3%) |
8 (20.0%) |
2.41 |
1.10–5.29 |
0.049 |
Cardiopulmonary bypass |
1888 (71.6%) |
24 (60.0%) |
0.59 |
0.31–1.11 |
0.11 |
Sternal wires ≤8 |
1708 (64.9%) |
39 (97.5%) |
21.09 |
2.89–153.8 |
<0.0001 |
Heavy sternal wires (gauge 7) |
497 (18.8%) |
6 (18.0%) |
0.75 |
0.31–1.81 |
0.68 |
Figure-of-eight sternal wiring |
134 (5.0%) |
2 (5.0%) |
0.98 |
0.23–4.11 |
0.97 |
Postoperative |
Blood transfusion |
1017 (38.6%) |
20 (50.0%) |
1.58 |
0.85–2.96 |
0.14 |
Low cardiac output syndrome |
37 (1.4%) |
3 (7.5%) |
5.68 |
1.67–19.27 |
0.021 |
IABP |
170 (6.4%) |
7 (17.5%) |
3.07 |
1.33–7.04 |
0.014 |
Inotrope infusion >24 h |
468 |
22 |
5.65 |
3.00–10.62 |
<0.0001 |
Gastrointestinal bleeding |
43 (1.6%) |
3 (7.5%) |
4.88 |
1.44–16.44 |
0.030 |
CVA |
34 (1.3%) |
2 (5.0%) |
4.02 |
0.93–17.34 |
0.10 |
Delirium |
301 (11.4%) |
5 (12.5%) |
1.10 |
0.43–2.84 |
0.80 |
Upper respiratory tract infection |
507 (19.3%) |
15 (37.5%) |
2.50 |
1.31–4.78 |
0.008 |
Respiratory failure (hypoxia) |
101 (3.8%) |
16 (40.0%) |
16.70 |
8.60–32.42 |
<0.0001 |
Mechanical ventilation >24 h |
307 (11.6%) |
19 (47.5%) |
6.85 |
3.64–12.89 |
0.001 |
AF (atrial fibrilation) |
640 (24.3%) |
10 (25.0%) |
1.03 |
0.50–2.13 |
0.85 |
Acute renal failure |
78 (2.9%) |
2 (5.0%) |
1.72 |
0.40–7.27 |
0.33 |
SSWI |
156 (5.9%) |
1 (2.5%) |
0.40 |
0.56–2.98 |
0.73 |
Re-opening |
138 (5.2%) |
1 (2.5%) |
0.46 |
0.06–3.39 |
0.72 |
Sepsis |
30 (1.1%) |
6 (15.0%) |
15.30 |
5.98–39.16 |
0.001 |
Mortality (during follow-up) |
65 (2.4%) |
8 (20.0%) |
9.87 |
4.37–22.25 |
<0.0001 |